A delivery device assembly for delivering a medical device to a target site within a patient includes a first polarizable tine and a second reactive tine that is not polarized. The first tine is connected to a first wire that has an electric coil surrounding a portion of the first wire. A current is passed through the electric wire to cause the polarizable tine to become polarized, thereby causing the reactive tine that is not coupled to the electric coil to move toward the polarized tine. The relative movement of the tines releases the medical device from its attachment to the tines.

Assemblies and methods for delivering an implant to a patient are disclosed. A delivery assembly can comprise an elongate tube, an outer magnetic member, and an inner magnetic member. The elongate tube extends from a proximal end portion to a distal end portion and defines a delivery lumen. The outer magnetic member can be movable along an outer surface of the tube; the inner magnetic member can be positioned within the delivery lumen and magnetically coupled to the outer magnetic member through a sidewall of the tube. The inner magnetic member can be movable through the delivery lumen when actuated by relative movement between the outer magnetic member and the tube. The delivery assembly can further comprise a syringe or an inflator/deflator couplable to a hub at the proximal end portion of the tube. The syringe or inflator/deflator can be used to urge fluid against a proximal end portion of the inner magnetic member.

Methods, devices and systems facilitate gastric retention of a variety of therapeutic devices. devices generally include a support portion for preventing the device from passing through the pyloric valve or esophagus wherein a retaining member may optionally be included on the distal end of the positioning member for further maintaining a position of the device in the stomach. Some embodiments are deliverable into the stomach through the esophagus, either by swallowing or through a delivery tube or catheter. Some embodiments are fully reversible. Some embodiments self-expand within the stomach, while others are inflated or otherwise expanded.

Methods, devices and systems facilitate gastric retention of a variety of therapeutic devices. devices generally include a support portion for preventing the device from passing through the pyloric valve or esophagus wherein a retaining member may optionally be included on the distal end of the positioning member for further maintaining a position of the device in the stomach. Some embodiments are deliverable into the stomach through the esophagus, either by swallowing or through a delivery tube or catheter. Some embodiments are fully reversible. Some embodiments self-expand within the stomach, while others are inflated or otherwise expanded.

The present invention provides for a joint fixation device and method utilizing magnetic members with at least one magnetic member positioned on each of opposite sides of a joint and secured to skeletal components. The magnetic members include at least one permanent magnet. The magnetic members can be configured to provide an attracting force or a repelling force. They can also be configured to provide a torque about the joint.

The invention relates to a device having an endovascular implant (1) for the introduction into blood vessels or body cavities of the human or animal body and an insertion aid (2), wherein the implant (1) and the insertion aid (2) being connected to each other via a detachment element (3) designed to be electrolytically corrodible so that after the implant (1) has been inserted into the body and a voltage has been applied an at least partial dissolution of the detachment element (3) takes place causing the implant (1) to be separated from its the insertion aid (3), with the detachment element (3) being made of a cobalt-chrome alloy containing at least 20% w/w cobalt and 10 to 40% w/w chrome.

Methods, devices and systems facilitate gastric retention of a variety of therapeutic devices. devices generally include a support portion for preventing the device from passing through the pyloric valve or esophagus wherein a retaining member may optionally be included on the distal end of the positioning member for further maintaining a position of the device in the stomach. Some embodiments are deliverable into the stomach through the esophagus, either by swallowing or through a delivery tube or catheter. Some embodiments are fully reversible. Some embodiments self-expand within the stomach, while others are inflated or otherwise expanded.

Pyloric valve corking devices are disclosed herein that generally include an occluding member, expanding from a first configuration to a larger second configuration, and a bridging member extending from the occluding member. The bridging member has a length that is adapted to pass at least partially through the gastric opening, so to enable the occluding member to obstruct the gastric opening, and that is also adapted to permit the occluding member to intermittently move relative to the gastric opening. A second occluding member may be attached to the distal end of the bridging member. The reduction in flow of gastric contents into the duodenum can be actively regulated using a pump or valve, or can be passively regulated with movements of the occluding device.

The present invention relates to an active tumor embolization device that actively drives an embolic substance with use of an X-ray system and a magnetic system, thereby being capable of minimizing the use of a catheter for injecting the embolic substance and preventing the necrosis of normal tissues caused by the embolic substance.

An occlusive implant system may include a delivery catheter, a core wire including a connection element disposed at a distal end, and a piece of expandable foam coupled to the connection element. An occlusive implant system may include a delivery catheter, a core wire may include a clamshell enclosure disposed at a distal end, and a piece of expandable foam, wherein the clamshell enclosure is configured to deliver and thereafter release the piece of expandable foam at a treatment site. An occlusive implant system may include a delivery catheter, a core wire including a connection element disposed at a distal end, a piece of expandable foam engaged with the connection element, and a polymer coating disposed on the piece of expandable foam, wherein the polymer coating is configured to degrade in vivo to release the piece of expandable foam from the connection element.